Literature DB >> 2007777

Smouldering hepatitis B virus replication in patients with chronic liver disease and hepatitis delta virus superinfection.

P Colombo1, F Di Blasi, S Magrin, C Fabiano, V Di Marco, L D'Amelio, F Lojacono, G Spinelli, A Craxì.   

Abstract

Hepatitis B virus deoxyribonucleic acid (HBV-DNA) was studied by Southern blot analysis in liver biopsy specimens from 75 HBsAg-positive patients with chronic liver disease living in southern Italy. Twenty-seven of the patients were hepatitis delta virus (HDV) superinfected. Intrahepatic HBV-DNA was detected in 54 (72%) patients, 32 (59%) of them with replicative forms. The presence of replicative forms was directly related to liver HBcAg and inversely related to liver HDAg, as shown by multivariate analysis. However, 14 patients with intrahepatic HBV-DNA non-replicative pattern and about half of HDV-infected patients were liver HBcAg and/or serum HBV-DNA positive, mostly in low amounts. Histological inflammatory activity was strongly related to liver HBcAg expression regardless of HDV superinfection, as confirmed by multivariate analysis. Our results confirm previous studies about the concordance between intrahepatic HBV-DNA replicative pattern and liver HBcAg expression and about inhibition by HDV of high-level HBV replication. However, they suggest that low-level HBV replication may have an important role in causing liver damage also among HDV-infected patients, in a population where the spreading of HBV and HDV is a naturally occurring event.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007777     DOI: 10.1016/0168-8278(91)90911-t

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis.

Authors:  Ellen Sloth Andersen; Jan Gerstoft; Nina Weis
Journal:  Int J Hematol       Date:  2010-08-05       Impact factor: 2.490

Review 2.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 3.  Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.

Authors:  Heiner Wedemeyer; Michael P Manns
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

4.  Correlation between hepatitis B viremia and the clinical and histological activity of chronic delta hepatitis.

Authors:  J L Lozano; J Crespo; F de la Cruz; F Casafont; M J Lopez-Arias; L Martín-Ramos; F Pons-Romero
Journal:  Med Microbiol Immunol       Date:  1994-07       Impact factor: 3.402

Review 5.  Pathogenesis of and New Therapies for Hepatitis D.

Authors:  Christopher Koh; Theo Heller; Jeffrey S Glenn
Journal:  Gastroenterology       Date:  2018-10-18       Impact factor: 22.682

Review 6.  Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte.

Authors:  Katja Giersch; Maura Dandri
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

Review 7.  Interplay between Hepatitis D Virus and the Interferon Response.

Authors:  Zhenfeng Zhang; Stephan Urban
Journal:  Viruses       Date:  2020-11-20       Impact factor: 5.048

8.  Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro.

Authors:  Maud Michelet; Dulce Alfaiate; Brieux Chardès; Caroline Pons; Suzanne Faure-Dupuy; Thomas Engleitner; Rayan Farhat; Tobias Riedl; Anne-Flore Legrand; Roland Rad; Michel Rivoire; Fabien Zoulim; Mathias Heikenwälder; Anna Salvetti; David Durantel; Julie Lucifora
Journal:  JHEP Rep       Date:  2021-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.